Impact of pharmacological treatment for heart failure after myocardial recovery in arrhythmia-induced cardiomyopathy.

25 August 2023 (17:15 - 17:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr Luis Manuel Dominguez Rodriguez

Ramon y Cajal Hospital, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail

Initiation, titration, and discontinuation - utilization of heart failure medicines in England (EVOLUTION HF UK)

Doctor R. Zhang (London, GB)

Abstract Slides Video

Presentation thumbnail

Statin and risk of dementia in patients with heart failure

Mrs Q. Ren (Hong Kong, HK)

Abstract Slides Video

Presentation thumbnail

Soluble guanylate cyclase in heart failure: A network meta-analysis and subgroup analyses of reduced and preserved ejection fraction.

Doctor M. Ibrahim (Flint, US)

Abstract Slides Video

Presentation thumbnail

Feasibility, efficacy and safety of early and rapid initiation of evidence-based treatment for patients with HFrEF- a real world experience of the "four drugs in four weeks" strategy

Doctor S. Sze (Leicester, GB)

Abstract Slides Video

Presentation thumbnail

Timing of angiotensin receptor-neprilysin inhibitor initiation in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry

Professor L. Lund (Stockholm, SE)

Abstract Slides Video

Access the full session

Session thumbnail

Pharmacological therapy in heart failure (2)

The Event

Event poster

ESC Congress 2023

25 August 2023 17:15 CET

You may be interested in

Congress Presentation

Long-term follow-up of the TRED-HF trial

Congress Presentation

Did we forget ARNI in the era of SGLTi?

Congress Presentation

Long-term outcomes in patients with non-ischemic dilated cardiomyopathy and improved ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources